At a moment when censorship anxiety is once again colliding with socially charged storytelling, The India Story: Slow Poison in Progress has landed in the spotlight. Coming close on the heels of Satluj being taken down from ZEE5, the Kajal Aggarwal and Shreyas Talpade-led film is now awaiting clearance from the Central Board of Film Certification ahead of its planned worldwide theatrical release on July 24, 2026.
That uncertainty has drawn even more attention to a film built around a deeply unsettling public health issue. Directed by Chettan DK, The India Story examines the widespread use of pesticides in farming and the damage they inflict on human health, turning a largely under-discussed crisis into the centre of its narrative.
Cbfc Delay Puts The India Story’s July 24 Release In Focus
The teaser has already generated conversation for its bold subject and pointed messaging, but the film’s immediate future depends on certification. With Satluj already becoming part of a larger conversation about how socially relevant stories find their way to viewers, The India Story has inevitably attracted added scrutiny as it waits for a formal green light.
Speaking about the situation, director Chettan DK said, “It has been a difficult time for films that dare to speak about uncomfortable realities. Seeing Satluj disappear from an OTT platform and now The India Story still waiting for its CBFC clearance is heartbreaking as a filmmaker. Our intention has never been to create controversy. We simply want to bring an important issue to the people through cinema. After years of research and hard work, all we ask is for the film to be given the opportunity to reach audiences. We remain hopeful that The India Story receives its clearance soon so people can watch it and form their own opinions.”
Presented by Zee Studios in association with MIG Production & Studios, the film arrives with backing that underlines its mainstream ambitions. Written and produced by Sagar B. Shinde, and directed by Chettan DK, the project is fronted by Kajal Aggarwal and Shreyas Talpade.
Its story channels that star power into a larger concern, focusing on the hidden dangers linked to pesticide-heavy farming and the food that reaches everyday households. Rather than treating the issue as background texture, the film places it at the heart of its dramatic conflict.
Kajal Aggarwal’s Star Power Expands The Film’s Reach
Kajal Aggarwal’s involvement gives The India Story a wider commercial lens at a crucial moment. With a strong presence across Hindi, Telugu and Tamil cinema, she brings immediate visibility to a film dealing with a subject that might otherwise have stayed on the margins of mainstream conversation.
That makes the CBFC delay especially significant. The India Story is aiming for a multilingual theatrical rollout on July 24, and Kajal’s presence helps position it as a film designed for broad audiences rather than a niche issue-based release. In that sense, the certification wait is not just a procedural hurdle. It affects the momentum of a film trying to bring a critical health conversation into the theatrical mainstream.
Stay tuned with us for the latest news, Hindi box office news, Hollywood news, OTT news, the latest Bollywood news, and the latest box office news.
